Alda ‐1, an aldehyde dehydrogenase‐2 agonist, causes deterioration in renal functions following ischemia–reperfusion injury due to crystalline nephropathy

Drug Development Research, EarlyView.

Source: Drug Development Research - October 6, 2018 Category: Drugs & Pharmacology Authors: Fayez T. Hammad, Suhail Al ‐Salam, Priya Yuvaraju, Loay Lubbad Source Type: research